Compare Stocks

→ A letter is coming from the 'Bureau of the Fiscal Service'. (From Stansberry Research) (Ad)

Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS).

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
ALFIW Alfi	$0.00	$0.00	$0.00 ▼ $2.88	N/A	N/A	6,051 shs	N/A
BTX Brooklyn ImmunoTherapeutics	$2.00 -1.5%	$2.23	$0.17 ▼ $10.10	$117.65M	4.61	515,543 shs	12,620 shs
CIDM Cinedigm	$1.02 -3.8%	$1.16	$0.27 ▼ $0.79	$190.65M	2.05	710,288 shs	92,750 shs
NLOK NortonLifeLock	$25.03 -1.0%	$21.62	$20.12 ▼ $30.92	$12.38B	0.76	5.78 million shs	6.59 million shs

10 Best Cheap Stocks to Buy Now

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.

Get This Free Report

Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
ALFIW Alfi	0.00%	0.00%	0.00%	0.00%	0.00%
BTX Brooklyn ImmunoTherapeutics	-1.48%	-1.00%	-6.98%	+19.76%	-29.12%
CIDM Cinedigm	-3.77%	+20.14%	-17.41%	-33.77%	+101,999,900.00%
NLOK NortonLifeLock	-0.08%	+6.69%	+22.88%	+17.18%	+61.90%

Elon to Transform U.S. Economy? (Ad)

A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” grift of the elites. And yet, while it threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth.

One company holds a near-total monopoly on it.

MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
ALFIW Alfi	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
BTX Brooklyn ImmunoTherapeutics	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
CIDM Cinedigm	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
NLOK NortonLifeLock	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Analyst Ratings

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
ALFIW Alfi	N/A	N/A	N/A	N/A
BTX Brooklyn ImmunoTherapeutics	N/A	N/A	N/A	N/A
CIDM Cinedigm	N/A	N/A	N/A	N/A
NLOK NortonLifeLock	N/A	N/A	N/A	N/A

Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
ALFIW Alfi	$200.68K	N/A	N/A	N/A	N/A	N/A
BTX Brooklyn ImmunoTherapeutics	N/A	N/A	N/A	N/A	N/A	N/A
CIDM Cinedigm	$72.33M	2.64	N/A	N/A	N/A	∞
NLOK NortonLifeLock	$2.82B	5.08	N/A	N/A	N/A	∞

Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
ALFIW Alfi	N/A	N/A	0.00	∞	N/A	N/A	N/A	N/A	N/A
BTX Brooklyn ImmunoTherapeutics	N/A	-$2.27	N/A	∞	N/A	N/A	N/A	N/A	N/A
CIDM Cinedigm	N/A	-$0.05	N/A	∞	N/A	N/A	N/A	N/A	N/A
NLOK NortonLifeLock	N/A	$1.43	17.50	∞	N/A	N/A	N/A	N/A	N/A

Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
ALFIW Alfi	N/A	N/A	N/A	N/A	N/A
BTX Brooklyn ImmunoTherapeutics	N/A	N/A	N/A	N/A	N/A
CIDM Cinedigm	N/A	N/A	N/A	N/A	N/A
NLOK NortonLifeLock	$0.50	2.00%	N/A	34.97%	N/A

Ownership

Institutional Ownership

Company	Institutional Ownership
ALFIW Alfi	N/A
BTX Brooklyn ImmunoTherapeutics	26.00%
CIDM Cinedigm	8.03%
NLOK NortonLifeLock	94.86%

Insider Ownership

Company	Insider Ownership
ALFIW Alfi	N/A
BTX Brooklyn ImmunoTherapeutics	20.50%
CIDM Cinedigm	16.40%
NLOK NortonLifeLock	3.30%

Miscellaneous

Company	Employees	Shares Outstanding	Free Float	Optionable
ALFIW Alfi	N/A	N/A	N/A	Not Optionable
BTX Brooklyn ImmunoTherapeutics	N/A	58.83 million	N/A	No Data
CIDM Cinedigm	140	186.92 million	N/A	Not Optionable
NLOK NortonLifeLock	N/A	571.37 million	N/A	Optionable

ALFIW, BTX, CIDM, and NLOK Headlines

Recent News About These Companies

May 13, 2024 | americanbankingnews.com

StockNews.com Begins Coverage on NortonLifeLock (NASDAQ:NLOK)

August 4, 2023 | investing.com

Gen Digital (GEN) Earnings Dates & Reports

August 1, 2023 | investorschronicle.co.uk

Time to question our dividend-based stock screen

July 8, 2023 | fool.com

Gen Digital (NASDAQ: GEN)

May 12, 2023 | msn.com

Gen Digital (GEN) Beats on Q4 Earnings and Revenue Estimates

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

Alfi

NASDAQ:ALFIW

Brooklyn ImmunoTherapeutics

NYSE:BTX

Eterna Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in creating transformative regenerative medicine treatments for cancer, blood disorders, and monogenic diseases. It offers IRX-2, a human cell-derived cytokine therapy, studying the safety and efficacy of IRX-2 in patients with head and neck cancer in Phase 2B. The company is headquartered in San Diego, CA.

Cinedigm

NASDAQ:CIDM

Cineverse Corp. is a global streaming technology and entertainment company. It owns and operates streaming channels, all powered by its advanced, proprietary technology platform. The firm currently features enthusiast brands for subscription video on demand (SVOD), advertising-based video on demand (AVOD), and free, ad-supported streaming television (FAST) channels. It entertains consumers around the globe by providing premium feature films and television series, enthusiast streaming channels, and technology services to some media, retail, and technology companies. The company was founded by A. Dale Mayo on March 31, 2000 and is headquartered in New York, NY.

NortonLifeLock

NASDAQ:NLOK

Gen Digital, Inc. engages in the provision of security, storage, and systems management solutions. The firm focuses on providing consumer cyber safety with its business solutions. The company was founded by Gary Hendrix in April 1982 and is headquartered in Tempe, AZ.

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial